Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update
Go back to Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update| (NASDAQ: FENC) | Delayed: 10.78 +0.23 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.55 | 52 Week High | $ | |||
| Open | $10.74 | 52 Week Low | $ | |||
| Day High | $10.99 | P/E | N/A | |||
| Day Low | $10.74 | EPS | $ | |||
| Volume | 128,575 | |||||
| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
